Furthermore, except for in a few small studies, the effect of IL-6 inhibition has only been investigated during the early post-transplant period; studies of IL-6 responsiveness later after allotransplantation would be of interest when considering IL-6 targeting in the prophylaxis and/or treatment of chronic GVHD [1]. This evidence concerns the gene IL6 and chronic graft versus host disease.